First Eagle Investments started to build up the position in Amedisys in Q1 2022 and continued to invest until Q1 2023. Since then they sold 101k shares. The investor completely sold their stake between Q2 2023 and Q4 2024.
Avg closing price
Price range
Sold -2.1k shares
Q4 2024
Avg closing price
$91.69
Price range
$83.52
-
$97.71
Sold 40.5% shares (-1.43k shares)
Q3 2024
Avg closing price
$97.57
Price range
$96.51
-
$98.45
Sold 86.0% shares (-21.8k shares)
Q1 2024
Avg closing price
$93.71
Price range
$92.15
-
$95.24
Sold 64.9% shares (-46.9k shares)
Q4 2023
Avg closing price
$93.40
Price range
$91.15
-
$95.90
Sold 4.5% shares (-3.43k shares)
Q3 2023
Avg closing price
$92.41
Price range
$89.84
-
$94.08
Sold 25.4% shares (-25.8k shares)
Q2 2023
Avg closing price
$82.04
Price range
$73.99
-
$92.60
Increased shares by 71.9% (+42.4k shares)
Q1 2023
Avg closing price
$86.52
Price range
$69.79
-
$100.33
Increased shares by 110.2% (+30.9k shares)
Q4 2022
Avg closing price
$90.16
Price range
$80.12
-
$105.34
Increased shares by 12.0% (+3.01k shares)
Q3 2022
Avg closing price
$119.25
Price range
$96.79
-
$131.14
Increased shares by 19932.0% (+24.9k shares)
Q2 2022